Skip to main content
Elsevier

Psychostimulants

  • 1st Edition, Volume 2 - May 5, 2020
  • Latest edition
  • Authors: George F. Koob, Michael A. Arends, Mandy L McCracken, Michel Le Moal
  • Language: English

A current survey and synthesis of the most important findings in our understanding of the neurobiological mechanisms of addiction are detailed in our Neurobiology of Addiction se… Read more

Data Mining & ML

Unlock the cutting edge

Up to 20% on trusted resources. Build expertise with data mining, ML methods.

Explore now

Description

A current survey and synthesis of the most important findings in our understanding of the neurobiological mechanisms of addiction are detailed in our Neurobiology of Addiction series, each volume addressing a specific area of addiction. Psychostimulants, Volume 2 in the series, explores the molecular and cellular systems in the brain responsible for psychostimulant addiction, including both direct/indirect sympathomimetics and nonsympathomimetics. This volume introduces the readers to the history of psychostimulant use. The authors clearly differentiate the neurobiological effects into three distinct stages of the addiction cycle: binge/intoxication, withdrawal/negative affect, and preoccupation/anticipation.

Key features

  • Highlights recent advances in psychostimulant addiction
  • Includes neurocircuitry, cellular and molecular neurobiological mechanisms of psychostimulant addiction
  • Defines the abuse and addiction potentials of both direct and indirect sympathomimetics and nonsympathomimetics

Readership

Primary: Researchers and graduate students in neuroscience, neurology, psychiatry, and addiction medicine

Table of contents

1. Definitions2. History of psychostimulant use 3. Physiological effects4. Behavioral effects 5. Pharmacokinetics6. Behavioral mechanism of action 7. Medical use, abuse, and addiction 8. Neurobiological effects 9. Summary

Review quotes

"This book is very technical and not geared to the average reader. It reviews the increased understanding of biological underpinnings of addiction and how, in some individuals, neurocircuitry is affected by psychostimulants, leading to their pathological use. Those who are involved or interested in the neurobiological underpinnings of addiction will find this a useful data update. These scientific understandings are also important for clinicians in the field to create a paradigm shift in their understanding of what drives these diseases."—Doody

Product details

  • Edition: 1
  • Latest edition
  • Volume: 2
  • Published: May 5, 2020
  • Language: English

About the authors

GK

George F. Koob

Dr. Koob is an internationally-recognized expert on alcohol and stress, and the neurobiology of alcohol and drug addiction. He is the Director of the National Institute on Alcohol Abuse and Alcoholism (NIAAA), overseeing a broad portfolio of alcohol research ranging from basic science to epidemiology, diagnostics, prevention, and treatment. Dr. Koob earned his doctorate in Behavioral Physiology from Johns Hopkins University in 1972. Prior to taking the helm at NIAAA, he served as Professor and Chair of the Scripps’ Committee on the Neurobiology of Addictive Disorders and Director of the Alcohol Research Center at the Scripps Research Institute. Early in his career, Dr. Koob conducted research in the Department of Neurophysiology at the Walter Reed Army Institute of Research and in the Arthur Vining Davis Center for Behavioral Neurobiology at the Salk Institute for Biological Studies. He was a post-doctoral fellow in the Department of Experimental Psychology and the MRC Neuropharmacology Unit at the University of Cambridge. Dr. Koob began his career investigating the neurobiology of emotion, particularly how the brain processes reward and stress. He subsequently applied basic research on emotions, including on the anatomical and neurochemical underpinnings of emotional function, to alcohol and drug addiction, significantly broadening knowledge of the adaptations within reward and stress neurocircuits that lead to addiction. Dr. Koob has authored more than 650 peer-reviewed scientific papers and is a co-author of The Neurobiology of Addiction.
Affiliations and expertise
Director, National Institute on Alcohol Abuse and Alcoholism and National, Institute on Drug Abuse, National Institutes of Health, Bethesda, MD, USA

MA

Michael A. Arends

Michael A. Arends received his Bachelor of Science degree from the University of California, San Diego. He is currently a Senior Research Assistant in the Committee on the Neurobiology of Addictive Disorders at The Scripps Research Institute and has worked in the field of the neurobiology of drug addiction for 20 years. He is Managing Editor for the journals Pharmacology Biochemistry and Behavior and Journal of Addiction Medicine. He has been acknowledged for his editorial and research assistance in over 450 scientific publications, including books, book chapters, and journal articles.
Affiliations and expertise
Senior Research Assistant, The Scripps Research Institute, La Jolla, CA, USA

MM

Mandy L McCracken

Dr. McCracken is a senior post-doctoral fellow at the National Institute on Drug Abuse in Bethesda, Maryland. She graduated with Honors in Biology and Psychology from The University of Texas at Austin and then earned a Ph. D. in Pharmacology and Toxicology at the College of Pharmacy at The University of Texas at Austin. Her research interests focus on molecular neurobiological mechanisms involved in neuroadaptations to drugs of abuse including opioids and alcohol. She has identified key sites on GABA-A receptors and glycine receptors important for the neuronal actions of alcohol. She has extensive experience in teaching as an Assistant Instructor with Dr. R. Adron Harris for the course Neurobiology of Addiction at The University of Texas at Austin.
Affiliations and expertise
Waggoner Center for Alcohol and Addiction Research, The University of Texas, Austin, TX, USA

ML

Michel Le Moal

Michel Le Moal, is Professor Emeritus of Neuroscience at the University of Bordeaux, France. He graduated in Medicine (1962) in Philosophy-Sociology and Natural Science and then Neurology (1967) and Psychiatry (1968). He completed a Doctoral in Science at the University of Bordeaux in 1974. In parallel with his academic life in Bordeaux, he spent time as an Associate Researcher and Professor at Caltech (1974) and at The Salk Institute and The Scripps Research Institute. At both institutions, he worked on dopamine neuron electrophysiology and investigated the roles of brain CRF and dopamine systems in behavior and drug addiction. He research interests concern behavior and adaptive processes, their biological foundations, and experimental psychopathology, a discipline he promoted. The concept of individual vulnerability to behavioral pathologies has been at the center of his working hypothesis. Dr. Le Moal has been the founder and director of several research laboratories at the Centre National de la Recherche Scientifique (CNRS) and Institut National de la Sante et de la Recherche Medicale and finally the Magendie Institute for Neuroscience and Biological Psychiatry in Bordeaux, France. He is an elected Fellow of the French National Academy of Sciences.
Affiliations and expertise
University of Bordeaux and Neurocentre Magendie, Inserm, Bordeaux, France

View book on ScienceDirect

Read Psychostimulants on ScienceDirect